Zhejiang Hisoar Pharmaceutical Co., Ltd. (SHE:002099)

Market Cap	9.33B
Revenue (ttm)	1.90B
Net Income (ttm)	-353.63M
Shares Out	1.59B
EPS (ttm)	-0.25
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	24,022,002
Average Volume	41,031,186
Open	6.39
Previous Close	5.91
Day's Range	5.86 - 6.39
52-Week Range	4.26 - 7.06
Beta	0.62
RSI	54.75
Earnings Date	Aug 29, 2025

About SHE:002099

Zhejiang Hisoar Pharmaceutical Co., Ltd. operates as a pharmaceutical company in China and internationally. The company offers antibiotics, cardiovascular products, hypoglycemic products, fine chemicals, dyes, intermediates, and other products, as well as clindamycin products. It also provides pharmaceutical, dyestuff, and other related services. The company was founded in 1966 and is based in Taizhou, China.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1966
• Employees: 2,611
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 002099

Financial Performance

In 2024, SHE:002099's revenue was 1.94 billion, a decrease of -10.75% compared to the previous year's 2.17 billion. Losses were -330.27 million, -21.38% less than in 2023.